UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039086
Receipt number R000044577
Scientific Title A study to evaluate menopausal symptoms in middle-aged women.
Date of disclosure of the study information 2020/01/31
Last modified on 2022/07/11 11:26:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to evaluate menopausal symptoms in middle-aged women.

Acronym

A study to evaluate menopausal symptoms in middle-aged women.

Scientific Title

A study to evaluate menopausal symptoms in middle-aged women.

Scientific Title:Acronym

A study to evaluate menopausal symptoms in middle-aged women.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate effects of a test food on the menopausal symptoms.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Questionnaire for assessment of menopausal symptoms

Key secondary outcomes

Blood test value


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Daily intakes of a test food for 6 months

Interventions/Control_2

Daily intakes of a placebo food for 6 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

1. Japanese premenopausal women aged over 40 but less than 60.
2. Individuals who have no climacteric disorder and have several climacteric symptoms.
3. Individuals who have normal estrogen production.
4. Individuals who have a normal menstrual cycles.
5. Individuals who can write informed consent, and come to the designated venue for this study.

Key exclusion criteria

1. Individuals being patient or have a history of serious disease of liver, kidney, heart, thyroid, internal organs and diabetes.
2. Individuals who have a history of ovariectomy or hysterectomy, who are taking medications for menopausal symptoms.
3. Individuals who have internal medical chronic diseases.
4. Individuals who are constantly using medicines and functional health foods that promote menopausal symptoms.
5. Shift workers including late-night shift.
6. Individuals who are pregnant, breastfeeding, and wish to become pregnant during the test.
7. Individuals who have excessively smoking or alcohol drinking habits.
8. Individuals judged inappropriate for the trial by the principal.

Target sample size

110


Research contact person

Name of lead principal investigator

1st name Susumu
Middle name
Last name Ishikawa

Organization

Medical Corporation Shoureikan Sinsapporo Seiryo hospital

Division name

Internal Medicine

Zip code

004-0004

Address

4-2-1-30, Atsubetsuhigashi, Atsubetsu-ku, Sapporo, Hokkaido

TEL

011-898-2151

Email

Ishikawa_seiryo@yahoo.co.jp


Public contact

Name of contact person

1st name Isao
Middle name
Last name Takehara

Organization

Clinical Support Corporation Co., Ltd.

Division name

PI-Food Service Division

Zip code

060-0061

Address

4-1, South 1 West 8, Chuo-ku, Sapporo, Hokkaido

TEL

011-223-3130

Homepage URL


Email

takehara@csc-smo.co.jp


Sponsor or person

Institute

Medical Corporation Shoureikan Sinsapporo Seiryo hospital

Institute

Department

Personal name



Funding Source

Organization

Asahi Quality & Innovations, Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of the Medical Corporation Hokubukai Utsukushigaoka Hospital

Address

61-1, Shinei, Kiyota-ku, Sapporo, Hokkaido

Tel

001-882-0111

Email

matsuda@ughp-cpc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

106

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 10 Month 11 Day

Date of IRB

2019 Year 10 Month 07 Day

Anticipated trial start date

2020 Year 02 Month 28 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 01 Month 08 Day

Last modified on

2022 Year 07 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044577


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name